JPMorgan Chase & Co’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-539
| Closed | -$997 | – | 6692 |
|
|
2023
Q2 | $997 | Buy |
+539
| New | +$997 | ﹤0.01% | 5550 |
|
|
2022
Q4 | – | Sell |
-1
| Closed | – | – | 6053 |
|
|
2022
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5921 |
|
|
2021
Q4 | – | Sell |
-19
| Closed | -$1K | – | 5980 |
|
|
2021
Q3 | $1K | Sell |
19
-2,397
| -99% | -$126K | ﹤0.01% | 5468 |
|
|
2021
Q2 | $231K | Sell |
2,416
-145
| -6% | -$13.9K | ﹤0.01% | 4423 |
|
|
2021
Q1 | $379K | Buy |
2,561
+132
| +5% | +$19.5K | ﹤0.01% | 4186 |
|
|
2020
Q4 | $340K | Buy |
2,429
+1,913
| +371% | +$268K | ﹤0.01% | 3947 |
|
|
2020
Q3 | $78K | Sell |
516
-129
| -20% | -$19.5K | ﹤0.01% | 4163 |
|
|
2020
Q2 | $113K | Buy |
+645
| New | +$113K | ﹤0.01% | 3913 |
|
|
2020
Q1 | – | Sell |
-687
| Closed | -$99K | – | 4867 |
|
|
2019
Q4 | $99K | Buy |
+687
| New | +$99K | ﹤0.01% | 4030 |
|
|
2018
Q3 | – | Sell |
-7
| Closed | -$1K | – | 4910 |
|
|
2018
Q2 | $1K | Hold |
7
| – | – | ﹤0.01% | 4728 |
|
|
2018
Q1 | $1K | Sell |
7
-48
| -87% | -$6.86K | ﹤0.01% | 4656 |
|
|
2017
Q4 | $41K | Buy |
+55
| New | +$41K | ﹤0.01% | 4190 |
|